News | January 21, 2008

New York Department of Health Authorizes AAAASF to Accredit Office-Based Surgery

January 22, 2008 - The American Association for Accreditation of Ambulatory Surgery Facilities (AAAASF) is authorized, as designated by the New York Department of Health, to be used by office-based surgery practices to meet new accreditation requirements in the state.

The New York law requires office-based surgery performed by physicians requiring moderate sedation, deep sedation, or general anesthesia, and certain liposuction procedures be performed in a setting that has obtained and maintained accreditation from an entity approved by the state health commissioner.

"AAAASF has worked with the State of New York over the last several years to assist in the development of the new law, and we believe that New York has taken a critical step to help ensure patient safety by requiring careful oversight of the office-based ambulatory medical and surgical care environment," said AAAASF President Dr. Alan Gold.

In New York and throughout the country, AAAASF already accredits more office-based surgery facilities than any other accrediting body and is reaching out to all physicians to offer a helping hand.

"We offer a concise, user-friendly set of standards that focuses on patient safety and best practices. Over the last several years, we have refined our standards and have tried to eliminate the busy work for facilities," said Jeff Pearcy, executive director. One component of the law requires reporting of unanticipated events after surgery to the state. AAAASF has already been requiring this type of reporting along with random case reviews for the last seven years.

"I have seen the accreditation industry incubate during my years of service at AAAASF, and my support for the process has never wavered. The significance of third party inspection, accreditation and peer review has gained tremendous validity as more states are incorporating accreditation concepts into laws, “ said Dr. Gold. "CMS recently deferred future Medicare inspections to deeming authorities such as AAAASF," he added.

For more information, visit www.aaaasf.org.

Related Content

PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
PET Imaging Agent Could Provide Early Diagnosis of Rheumatoid Arthritis

Coronal 18F-FEDAC PET/CT section of a mouse with collagen-induced arthritis. (A) On day 23 and day 37, increased uptake is noted in the front and hind paws of this mouse with collagen-induced arthritis. (B) Predictive performance of day 23 18F-FEDAC uptake for the development of clinical arthritis. ROC = receiver operating characteristic; Sn = sensitivity; Sp = specificity. Credit: Seoul National University and Ewha Womans University, Seoul, South Korea

News | PET Imaging | May 17, 2018
A novel positron emission tomography (PET) tracer developed by Korean researchers can visualize joint inflammation and...
PET Imaging Shows Protein Clumping May Contribute to Heart Failure Development
News | PET Imaging | May 11, 2018
A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to accumulate in the...
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in...
Novel PET Agent Could Help Guide Therapy for Brain Diseases

Rat brain 11C‐Me‐NB1 PET images (0‐60 min) superimposed on an MRI template. Credit: SD Krämer et al., ETH Zurich, Zurich, Switzerland

News | PET Imaging | April 10, 2018
Researchers have developed a new imaging agent that could help guide and assess treatments for people with various...
Imaging agent helps predict success of lung cancer therapy
News | Oncology Diagnostics | March 08, 2018
March 8, 2018 – Doctors contemplating the best therapy for...
Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer
News | PET Imaging | February 21, 2018
Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive...
PSMA PET-CT Clearly Differentiates Prostate Cancer from Benign Tissue

68Ga-PSMA PET/CT images showing multifocal PCA in peripheral zone with GS of 5 1 5 5 10. (A and C) Axial PET images. (B and D) Fused PET/CT images. SUVmax of lesion in B was 84.3 and that of lesion in D was 5.7. IRS was 3, and 80% of cells were stained. Credit: Senior author V Prasad, Charité Universitätsmedizin Berlin, Berlin, Germany.

News | PET-CT | February 05, 2018
February 5, 2018 — Using nuclear medicine...
PET Tracer Measures Damage From Multiple Sclerosis in Mouse Models
News | PET Imaging | January 24, 2018
January 24, 2018 — The loss or damage of myelin, a cellular sheath that surrounds and insulates nerves, is the hallma
Overlay Init